Cynata Therapeutics Limited (ASX:CYP) Treats First Patient in Kidney Transplant Trial
Cynata Therapeutics (ASX:CYP) has successfully treated its first patient in a kidney transplant clinical trial with CYP-001.
Cynata Therapeutics (ASX:CYP) has successfully treated its first patient in a kidney transplant clinical trial with CYP-001.
Vinyl Group (ASX:VNL) has announced their acquisition of Concrete Playground for $5 million, enhancing their EBITDA and accelerating cash flow.
Buxton Resources Ltd reports significant high-grade graphite results at Graphite Bull, anticipating further resource growth.
LTR Pharma launches its online telehealth platform for men’s health, enabling access to SPONTAN treatment ahead of schedule.
BCAL Diagnostics Limited (ASX: BDX) receives NATA accreditation, advancing its BREASTEST® commercialisation efforts.
Capitol Health announces the effective implementation of its acquisition by Integral Diagnostics, leading to trading suspension on the ASX.
LiveHire Ltd (ASX: LVH) recommended shareholders accept Humanforce’s unconditional takeover offer at $0.045 per share.
Titomic Limited announces the successful co-development and acceptance of a new cold spray standard with SAE International, enhancing its market position.
HealthCo Healthcare & Wellness REIT (HCW) announces property valuations increase and declares distribution for December 2024.
PainChek Limited (ASX:PCK) reports growth in implemented licenses and new government partnerships enhancing market opportunities.